To address the shortage of neurological care, virtual neurology clinic Neura Health has received an $11.4 million Series A funding round. The round, which brings the company’s total funding to $22 million, was led by the American Heart Association’s Go Red for Women Venture Fund, marking the fund’s first-ever investment.
In April 2025, Lisa Suennen, managing partner of American Heart Association Ventures, discussed with Healthcare Innovation the models developed for it to invest in startups focused on cardiac and brain health. At the time she called the Go Red for Women Venture Fund a new program. “It started to come to life last year. We conceived it and kicked off the fundraising and hired the team,” she said. “It has raised almost $60 million of the $75 million. It is a donor-funded fund related to women’s health, but through the lens of cardiovascular and brain health. It focuses on how cardiovascular disease and brain health show up differentially, disproportionately, uniquely for women.”
Neura says it is addressing an unmet need for sub-specialty, patient-focused neurological support. The startup says that 145 million Americans live with a neurological condition, yet the average wait time for an appointment with a neurologist is at least 4–6 months due to a nationwide provider shortage (American Academy of Neurology). Neura is seeking to close the access gap with a platform that combines virtual visits with neurologists and neurological sub-specialists, alongside AI-powered workflows, an app with integrated symptom tracking, streamlined care navigation, and personalized education and coaching. Neura claims to be the only tech-enabled care model to support the full spectrum of neurology conditions, including eight major condition categories: headache and migraine, epilepsy, chronic pain, concussion, stroke recovery, dementia, and undiagnosed neurological symptoms.
Neura recently expanded into memory care. Currently, there is only one cognitive neurologist for every one million dementia patients, according to the American Academy of Neurology. Neura’s memory care offering will enable patients to receive earlier diagnoses, ongoing symptom management, and wraparound support.
To date, Neura has served over 43,000 patients nationwide, partnering with leading health systems like Sentara Health to extend their bandwidth and treat the widest array of neurological conditions. Neura is also in network with more than 40 health plans, including Aetna, Blue Shield of California, Cigna, Sana, Anthem Blue Cross, TriWest, and Medicare. Its referral partnerships with life sciences leaders such as Theranica and Otolith Labs exemplify the broad need for coordinated, whole-person neurological care.
Neura also said that its real-world evidence datasets in neurology has drawn interest from pharmaceutical manufacturers.
“After struggling to find and manage care for my own chronic nerve pain, I saw firsthand the gaps in care that prevent millions of people like me from finding relief and recovery from chronic neurological conditions,” said Elizabeth Burstein, CEO and Co-Founder of Neura Health, in a statement. “We’ve built Neura Health to bring the highest quality neurological care directly to patients across the country, providing them with empathy, hand-holding, and support as they navigate their care journeys. Neura’s Series A will help the company advance its mission of making high-quality neurological care accessible to all, accelerating growth with payers and health systems, expanding into new condition areas, and continuing to deliver compassionate, expert support at every step of the patient journey.”
Additional participants include Norwest Venture Partners, Koch Disruptive Technologies, Esplanade Ventures, Pear VC, Correlation Ventures, and E12 Ventures.
